251 related articles for article (PubMed ID: 16493609)
21. Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia.
Castaman G; Rodeghiero F; Dini E
Haematologica; 1990; 75(6):567-9. PubMed ID: 2098299
[TBL] [Abstract][Full Text] [Related]
22. Thrombosis in children receiving L-asparaginase. Determining patients at risk.
Shapiro AD; Clarke SL; Christian JM; Odom LF; Hathaway WE
Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):400-5. PubMed ID: 8214362
[TBL] [Abstract][Full Text] [Related]
23. Protein C, S and antithrombin III levels in patients with acute mechanical valve thrombosis.
Tütün U; Ulus AT; Aksöyek A; Kaplan S; Ayaz S; Yilmaz S; Birincioglu L; Katircioglu SF
Panminerva Med; 2002 Dec; 44(4):359-63. PubMed ID: 12434119
[TBL] [Abstract][Full Text] [Related]
24. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
25. [Effects of pulse-therapy on natural anticoagulant system of the endothelium in nonspecific aortoarteritis].
Gur'eva MS; Baranov AA; Bagrakova SV; Nasonov EL; Zharikova DG
Ter Arkh; 2003; 75(5):52-6. PubMed ID: 12847899
[TBL] [Abstract][Full Text] [Related]
26. [Protein C, protein S and antithrombin III at normal delivery and during abruptio placentae].
Thiam D; Diop S; Ba Gueye M; Fall K; Toure AO; Diadhiou F; Diakhate L
Dakar Med; 1999; 44(1):54-7. PubMed ID: 10797988
[TBL] [Abstract][Full Text] [Related]
27. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
28. Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.
Layden BT; Joseph M; Tallman MS; Platanias LC
Acta Haematol; 2007; 118(4):242-3. PubMed ID: 18087146
[TBL] [Abstract][Full Text] [Related]
29. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase.
Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S
Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591
[TBL] [Abstract][Full Text] [Related]
30. [Superior sagittal sinus thrombosis following L-asparaginase therapy of acute lymphoblastic leukemia].
Watanabe I; Sakai I; Matsumoto I
Rinsho Ketsueki; 1992 Mar; 33(3):343-8. PubMed ID: 1578639
[TBL] [Abstract][Full Text] [Related]
31. Parameters of haemostasis during acute venous thrombosis.
Reiter W; Ehrensberger H; Steinbrückner B; Keller F
Thromb Haemost; 1995 Aug; 74(2):596-601. PubMed ID: 8584990
[TBL] [Abstract][Full Text] [Related]
32. Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment.
Chojnowski K; Wawrzyniak E; Treliński J; Niewiarowska J; Cierniewski C
Leuk Lymphoma; 1999 Dec; 36(1-2):77-84. PubMed ID: 10613452
[TBL] [Abstract][Full Text] [Related]
33. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.
Oner AF; Gürgey A; Kirazli S; Okur H; Tunç B
Leuk Lymphoma; 1999 Apr; 33(3-4):361-4. PubMed ID: 10221516
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of plasma activity level of anticoagulant proteins in patients with acute lymphoblastic leukemia in Shafa hospital Ahwaz 2010.
Jalali MT; Khosravi M; Keikhaei B; Dehuori F; Latifi M
Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):1045-51. PubMed ID: 22913155
[TBL] [Abstract][Full Text] [Related]
35. Study of protein C, protein S, and antithrombin III in hypoxic newborns.
El Beshlawy A; Hussein HA; Abou-Elew HH; Abdel Kader MS
Pediatr Crit Care Med; 2004 Mar; 5(2):163-6. PubMed ID: 14987347
[TBL] [Abstract][Full Text] [Related]
36. Thrombotic complications during induction chemotherapy of acute childhood lymphoblastic leukemia.
Kankirawatana S; Veerakul G; Sanpakit K; Tanphaichitr VS; Akkabutr P; Suwantol L; Mahasandana C
J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S549-57. PubMed ID: 12403231
[TBL] [Abstract][Full Text] [Related]
37. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
[TBL] [Abstract][Full Text] [Related]
38. Plasma protein C and antithrombin III in patients with acute leukemia.
Cucuianu A; Brudaşcă I; Colhon D; Paţiu M; Basarab C; Cucuianu M
Rom J Intern Med; 1994; 32(3):209-14. PubMed ID: 7866337
[TBL] [Abstract][Full Text] [Related]
39. [May (must?) in a for recurrent thrombophlebitis [with normal AT III/ protein C+S] fully "marcumarized" patient (with [otherwise?] negative contraindications) with acute posterior wall infarct (15 min "old") a brief lysis therapy be instituted?].
Seitz R
Internist (Berl); 1995 Dec; 36(12):1202. PubMed ID: 8567228
[No Abstract] [Full Text] [Related]
40. [Expanded blood coagulation screening--a necessity in diagnosis and therapy of thrombosis?].
Wozniak G; Montag H; Alemany J
Vasa Suppl; 1992; 35():92-3. PubMed ID: 1481078
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
